MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 122, Issue 5, Pages 705-714
Publisher
Springer Science and Business Media LLC
Online
2020-01-10
DOI
10.1038/s41416-019-0703-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells
- (2018) Yuxia Li et al. BMC CANCER
- Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands
- (2018) Salvatore Savino et al. DALTON TRANSACTIONS
- MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer
- (2018) Dong-Mei Wu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway
- (2018) Feng Cheng et al. MICROBIAL PATHOGENESIS
- Secretory microRNAs as biomarkers of cancer
- (2018) Kazuharu Kai et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancer
- (2018) James L. Thorne et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer
- (2018) Wenjing Ma et al. CANCER BIOLOGY & THERAPY
- lncRNA DLG1-AS1 Promotes Cell Proliferation by Competitively Binding with miR-107 and Up-Regulating ZHX1 Expression in Cervical Cancer
- (2018) Xiaohui Rui et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway
- (2017) Lingxi Jiang et al. HEPATOLOGY
- The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required
- (2017) Kai Zhao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)
- (2017) Yixue Gu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Polyphenolics from mango (Mangifera indica L.) suppress breast cancer ductal carcinoma in situ proliferation through activation of AMPK pathway and suppression of mTOR in athymic nude mice
- (2017) Matthew J. Nemec et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin
- (2017) Shu-Nan Wang et al. MOLECULAR THERAPY
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chitosan oligosaccharide suppresses tumor progression in a mouse model of colitis-associated colorectal cancer through AMPK activation and suppression of NF-κB and mTOR signaling
- (2016) Tharinee Mattaveewong et al. CARBOHYDRATE POLYMERS
- Crosstalk among proteome, acetylome and succinylome in colon cancer HCT116 cell treated with sodium dichloroacetate
- (2016) Danxi Zhu et al. Scientific Reports
- miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells
- (2015) Mingjun Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells
- (2015) Kah Tan Allen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab
- (2014) E Zulato et al. BRITISH JOURNAL OF CANCER
- MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8
- (2014) Yan-qiang Song et al. Diagnostic Pathology
- AMPK Activation by Oncogenesis Is Required to Maintain Cancer Cell Proliferation in Astrocytic Tumors
- (2013) M. Rios et al. CANCER RESEARCH
- miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4
- (2012) H.-Y. Chen et al. CANCER RESEARCH
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse model for metastatic breast cancer
- (2011) Ian F Robey et al. BMC CANCER
- In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines
- (2011) Wolfgang Fiebiger et al. Clinical & Translational Oncology
- MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases
- (2011) Beatrice M Filippi et al. EMBO JOURNAL
- Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells
- (2011) Serena Vella et al. INTERNATIONAL JOURNAL OF CANCER
- miR451 and AMPK Mutual Antagonism in Glioma Cell Migration and Proliferation: A Mathematical Model
- (2011) Yangjin Kim et al. PLoS One
- Dichloroacetate (DCA) sensitizes both wild‐type and over expressingBcl‐2prostate cancer cells in vitro to radiation
- (2008) Wengang Cao et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started